Toll-like receptors in the mechanism of tributyltin-induced production of pro-inflammatory cytokines, IL-1β and IL-6

Toxicology. 2022 Apr 30:472:153177. doi: 10.1016/j.tox.2022.153177. Epub 2022 Apr 9.

Abstract

Tributyltin (TBT) is an environmental contaminant due to its use in a variety of applications as a biocide, including in marine anti-fouling paints. It has been detected in a number of human tissues including blood. Previous studies have shown that exposure to TBT increases the cellular production (secretion plus intracellular levels) of the pro-inflammatory cytokines IL-1β and IL-6 by peripheral blood mononuclear cells (PMBCs) and this increase requires MAPK activation. Toll-like receptors (TLR) activate immune cells to produce pro-inflammatory cytokines in response to pathogen associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs) leading to activation of MAPKs as well as other intracellular components that regulate cytokine production. The current study shows that selective inhibition of TLRs 4,1/2, and 8 diminishes the ability of TBT to stimulate IL-1β and IL-6 production. However, selective inhibition of TLR3 enhanced the TBT-induced production of IL-1β. This indicates that TBT may be either directly or indirectly interacting with certain TLR receptors as part of its mechanism of stimulating pro-inflammatory cytokine production. These results provide an important advance in understanding TBT stimulation of IL-1β and IL-6, which has the potential to cause chronic inflammation and its attendant pathologies.

Keywords: Pro-inflammatory cytokines; TLR; Tributyltin.

MeSH terms

  • Cytokines*
  • Humans
  • Interleukin-1beta / metabolism*
  • Interleukin-6*
  • Leukocytes, Mononuclear
  • Toll-Like Receptors
  • Trialkyltin Compounds

Substances

  • Cytokines
  • Interleukin-1beta
  • Interleukin-6
  • Toll-Like Receptors
  • Trialkyltin Compounds
  • tributyltin